Open AccessImmune reconstitution, glomerulonephritis, and successful treatment with rituximab
Author(s) -
George Vasquez-Rios,
John C. Edwards,
Saketh Tummala,
Ashley Chapel,
Ramez Sunna,
David S. Brink,
Christopher Laohathai,
Thanh-Mai Vo
Publication year - 2020
Publication title -
clinical nephrology - case studies
Language(s) - English
Resource type - Journals
ISSN - 2196-5293
DOI - 10.5414/cncs110061
Subject(s) - medicine , rituximab , alemtuzumab , anti neutrophil cytoplasmic antibody , proteinuria , renal biopsy , glomerulonephritis , methylprednisolone , pathology , gastroenterology , kidney , immunology , antibody , vasculitis , lymphoma , disease
Alemtuzumab can induce secondary autoimmunity affecting multiple organs. While kidney involvement is uncommon, it can be associated with devastating forms of glomerulonephritis (GN).